Description:When two executives in the pharmaceutical industry step forward to complain the drug test results being published are not accurate, they don’t expect to be fired; and they don’t expect anyone to be stalked, beaten or killed. They have no idea what they will be up against for revealing a secret that will cost their employer billions of dollars. Aligor Pharmaceuticals has a new drug. One that they say will revolutionize cancer treatment, with the possibility of rescuing many in the final stages of the disease. And Delexane is only weeks from FDA approval as the phase three trials conclude. The product is already generating millions of dollars with news of its arrival causing the stock price to soar. In a couple of months, the product will be released and millions battling cancer are expected to benefit. The problem is, the sixty-five percent success rate that resulted in the first two phases of the drug test has fallen to only twelve percent in phase three, the biggest test group of the product trials, but Aligor continues to publicize a sixty-five percent success rate. Witnessing the failures of phase three, Aligor executives Martin Cardenas and Justin Palmer repeatedly approach Aligor’s top management about the discrepancy between the results the company continues to publish, and the results actually documented. To the CEO, their continued silence becomes a question of loyalty and when they author a letter that would disclose what was happening to regulatory authorities, they are both abruptly terminated—and the fight begins. This is a timely story of a drug that is desperately needed in society. But Delexane is about to rushed to the market and released prematurely, with its true performance and side effects hidden from the public. And when a drug company doesn’t disclose the real data about a potential new drug to regulators or the public, there are millions of potential victims. Attorney Scott Winslow accepts representation of fired executives Cardenas and Palmer and goes to war against the pharma giant. As the battle rages, Martin Cardenas and Justin Palmer find themselves stalked and threatened and Investigator Lee Henry goes to extraordinary lengths to discover and access evidence that will make a difference. And you will find yourself up late reading as compelling characters go to battle and bring you face to face with the unexpected.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with A Secret To Die For (Scott Winslow Legal Mysteries Book 3). To get started finding A Secret To Die For (Scott Winslow Legal Mysteries Book 3), you are right to find our website which has a comprehensive collection of manuals listed. Our library is the biggest of these that have literally hundreds of thousands of different products represented.
Pages
—
Format
PDF, EPUB & Kindle Edition
Publisher
—
Release
—
ISBN
A Secret To Die For (Scott Winslow Legal Mysteries Book 3)
Description: When two executives in the pharmaceutical industry step forward to complain the drug test results being published are not accurate, they don’t expect to be fired; and they don’t expect anyone to be stalked, beaten or killed. They have no idea what they will be up against for revealing a secret that will cost their employer billions of dollars. Aligor Pharmaceuticals has a new drug. One that they say will revolutionize cancer treatment, with the possibility of rescuing many in the final stages of the disease. And Delexane is only weeks from FDA approval as the phase three trials conclude. The product is already generating millions of dollars with news of its arrival causing the stock price to soar. In a couple of months, the product will be released and millions battling cancer are expected to benefit. The problem is, the sixty-five percent success rate that resulted in the first two phases of the drug test has fallen to only twelve percent in phase three, the biggest test group of the product trials, but Aligor continues to publicize a sixty-five percent success rate. Witnessing the failures of phase three, Aligor executives Martin Cardenas and Justin Palmer repeatedly approach Aligor’s top management about the discrepancy between the results the company continues to publish, and the results actually documented. To the CEO, their continued silence becomes a question of loyalty and when they author a letter that would disclose what was happening to regulatory authorities, they are both abruptly terminated—and the fight begins. This is a timely story of a drug that is desperately needed in society. But Delexane is about to rushed to the market and released prematurely, with its true performance and side effects hidden from the public. And when a drug company doesn’t disclose the real data about a potential new drug to regulators or the public, there are millions of potential victims. Attorney Scott Winslow accepts representation of fired executives Cardenas and Palmer and goes to war against the pharma giant. As the battle rages, Martin Cardenas and Justin Palmer find themselves stalked and threatened and Investigator Lee Henry goes to extraordinary lengths to discover and access evidence that will make a difference. And you will find yourself up late reading as compelling characters go to battle and bring you face to face with the unexpected.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with A Secret To Die For (Scott Winslow Legal Mysteries Book 3). To get started finding A Secret To Die For (Scott Winslow Legal Mysteries Book 3), you are right to find our website which has a comprehensive collection of manuals listed. Our library is the biggest of these that have literally hundreds of thousands of different products represented.